About GeneMatters
GeneMatters is a company based in Minneapolis (United States) founded in 2016 by Jill Davies was acquired by Genome Medical in August 2021.. GeneMatters has raised $10.33 million across 3 funding rounds from investors including Genome Medical and Invenshure. GeneMatters offers products and services including Genetic Counseling and Genetic Test Ordering.
- Headquarter Minneapolis, United States
- Founders Jill Davies
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genome Medical, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.33 M (USD)
in 3 rounds
-
Latest Funding Round
$10.2 M (USD), Series A
Jul 21, 2020
-
Investors
Genome Medical
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Genome Medical
(Aug 30, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeneMatters
GeneMatters offers a comprehensive portfolio of products and services, including Genetic Counseling and Genetic Test Ordering. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Genetic counseling is provided to assist patients and families in understanding genetic factors that may affect health outcomes.
Genetic tests are ordered by providers to evaluate potential genetic conditions, where results are interpreted and shared with patients.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of GeneMatters
GeneMatters has successfully raised a total of $10.33M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.2 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.2M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series A - GeneMatters | Valuation |
investors |
|
| May, 2019 | Amount | Seed - GeneMatters | Valuation |
investors |
|
| Jun, 2016 | Amount | Seed - GeneMatters | Valuation | Invenshure |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GeneMatters
GeneMatters has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Genome Medical and Invenshure. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Invenshure is focused on building companies from institutional IP.
|
Founded Year | Domain | Location | |
|
Genomic testing services are provided clinically and directly to consumers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeneMatters
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GeneMatters
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genematters Comparisons
Competitors of GeneMatters
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GeneMatters
When was GeneMatters founded?
GeneMatters was founded in 2016.
Where is GeneMatters located?
GeneMatters is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Who is the current CEO of GeneMatters?
Jill Davies is the current CEO of GeneMatters. They have also founded this company.
Is GeneMatters a funded company?
GeneMatters is a funded company, having raised a total of $10.33M across 3 funding rounds to date.
What does GeneMatters do?
GeneMatters was founded in 2016 in Minneapolis, United States, as a provider of telehealth-enabled genetic services focused on rare diseases. Genetic counseling, test ordering, and clinical trial matching are offered to support patients, families, and health organizations. Partnerships with hospitals, health systems, and genetic testing labs are maintained to enhance access to services and accelerate diagnoses for rare conditions.
What products or services does GeneMatters offer?
GeneMatters offers Genetic Counseling and Genetic Test Ordering.
Who are GeneMatters's investors?
GeneMatters has 2 investors. Key investors include Genome Medical, and Invenshure.